BDBM282933 6-(4-(3-chloro-4-fluorophenyl)-1-(2-hydroyxethyl)-1H- imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carboxamide::US10287295, Example 138'::US9884868, Example 138'

SMILES: NC(=O)c1cnc2ccc(nn12)-c1c(ncn1CCO)-c1ccc(F)c(Cl)c1

InChI Key: InChIKey=GZUQQNFNGSZHRU-UHFFFAOYSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 282933   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
TGF-beta receptor type-1 (Homo sapiens (Human))	BDBM282933 (6-(4-(3-chloro-4-fluorophenyl)-1-(2-hydroyxethyl)-...) Show SMILES NC(=O)c1cnc2ccc(nn12)-c1c(ncn1CCO)-c1ccc(F)c(Cl)c1 Show InChI InChI=1S/C18H14ClFN6O2/c19-11-7-10(1-2-12(11)20)16-17(25(5-6-27)9-23-16)13-3-4-15-22-8-14(18(21)28)26(15)24-13/h1-4,7-9,27H,5-6H2,(H2,21,28)	PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	7.4	25
Rigel Pharmaceuticals, Inc.; Bristol-Myers Squibb Company US Patent					Assay Description Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGF-βR1 T204D or...				US Patent US9884868 (2018) BindingDB Entry DOI: 10.7270/Q20P122M
					More data for this Ligand-Target Pair
TGF-beta receptor type II (Homo sapiens (Human))	BDBM282933 (6-(4-(3-chloro-4-fluorophenyl)-1-(2-hydroyxethyl)-...) Show SMILES NC(=O)c1cnc2ccc(nn12)-c1c(ncn1CCO)-c1ccc(F)c(Cl)c1 Show InChI InChI=1S/C18H14ClFN6O2/c19-11-7-10(1-2-12(11)20)16-17(25(5-6-27)9-23-16)13-3-4-15-22-8-14(18(21)28)26(15)24-13/h1-4,7-9,27H,5-6H2,(H2,21,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.98E+3	n/a	n/a	n/a	n/a	n/a	n/a
University of Wisconsin at Madison					Assay Description Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGF-βR1 T204D or...				J Med Chem 51: 7243-52 (2008) BindingDB Entry DOI: 10.7270/Q2B85BFB
					More data for this Ligand-Target Pair
TGF-betaR1 T204D (Homo sapiens (Human))	BDBM282933 (6-(4-(3-chloro-4-fluorophenyl)-1-(2-hydroyxethyl)-...) Show SMILES NC(=O)c1cnc2ccc(nn12)-c1c(ncn1CCO)-c1ccc(F)c(Cl)c1 Show InChI InChI=1S/C18H14ClFN6O2/c19-11-7-10(1-2-12(11)20)16-17(25(5-6-27)9-23-16)13-3-4-15-22-8-14(18(21)28)26(15)24-13/h1-4,7-9,27H,5-6H2,(H2,21,28)	PDB MMDB NCI pathway Reactome pathway KEGG B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	n/a
University of Wisconsin at Madison					Assay Description Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGF-βR1 T204D or...				J Med Chem 51: 7243-52 (2008) BindingDB Entry DOI: 10.7270/Q2B85BFB
					More data for this Ligand-Target Pair
TGF-beta receptor type II (Homo sapiens (Human))	BDBM282933 (6-(4-(3-chloro-4-fluorophenyl)-1-(2-hydroyxethyl)-...) Show SMILES NC(=O)c1cnc2ccc(nn12)-c1c(ncn1CCO)-c1ccc(F)c(Cl)c1 Show InChI InChI=1S/C18H14ClFN6O2/c19-11-7-10(1-2-12(11)20)16-17(25(5-6-27)9-23-16)13-3-4-15-22-8-14(18(21)28)26(15)24-13/h1-4,7-9,27H,5-6H2,(H2,21,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.98E+3	n/a	n/a	n/a	n/a	n/a	n/a
Rigel Pharmaceuticals, Inc.; Bristol-Myers Squibb Company US Patent									US Patent US9884868 (2018) BindingDB Entry DOI: 10.7270/Q20P122M
					More data for this Ligand-Target Pair